US FDA Needs Plan For Addressing Inspection Backlog Post-COVID, GAO Says

 
• By Joanne S. Eglovitch
  
Facility inspection
GAO Tells FDA Not To Compromise High-Risk Facility Inspections Due To COVID-19 Backlog • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance